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Osseointegrated total hip replacement
connected to a lower limb prosthesis: a
proof-of-concept study with three cases
Aditya Khemka1,2,3* , Chalak I. FarajAllah4, Sarah J. Lord1,3,5, Belinda Bosley2 and Munjed Al Muderis1,2,4
Abstract
Background: Osseointegrated implants are a suitable alternative for prosthetic attachment in individuals with a
transfemoral amputation, who are unable to wear a socket. However, the small bone-implant contact area, reduced
muscular leverage, and osteoporosis contraindicate osseointegrated implant use in transfemoral amputees with
osteoporosis and a short residuum. We report on the feasibility of combining total hip replacement (THR) with an
osseointegrated implant for prosthetic attachment.
Methods: We retrospectively reviewed the cases of three transfemoral amputees who underwent osseointegration
with THR between 2013 and 2014. In a two-stage procedure, a custom-made femoral prosthesis was connected to
a THR with a modular revision stem and a stoma was created. Clinical outcomes were assessed at baseline and
1.5–2.5-year follow-up using standard measures of health-related quality of life, ambulation, and activity levels including
the Short Form-36 (SF-36), Questionnaire for Transfemoral Amputees (Q-TFA), Timed Up and Go test, and 6-min walk test.
Results: Patient age ranged from 35 to 65 years. There were no major adverse events, but there was one case of
superficial infection. All patients showed improved Q-TFA and SF-36 scores. Two patients who were wheelchair-bound
at baseline became community ambulators, and the third patient exhibited improved ambulation.
Conclusions: This study demonstrated the feasibility of combining a THR with an osseointegrated implant in
transfemoral amputees.
Keywords: Osseointegration, Joint replacement, Transfemoral, Amputee
Background
Traditionally, transfemoral amputees have been rehabili-
tated using a socket prosthesis. However, over the past
two decades, innovative surgical techniques that connect
the lower limb prosthesis directly to the bone via
osseointegration have emerged. These techniques were
developed to overcome reductions in amputee quality of
life, which occur secondary to socket-residuum interface
problems including significant discomfort, poor fit, lack
of rotational control, reduced proprioception, and asso-
ciated energy loss due to prosthetic pistoning [1–3]. The
structural and functional connection between the
macroporous surface of metal implants and living bone
[4] is achieved by either bone on-growth (screw fixation
implants) [5] or bone penetration and in-growth (press-
fit implants) [6].
Previous studies have reported the benefits of osseointe-
grated implants in transfemoral amputees. These included
improvements in quality of life [5], prosthetic use [7], body
image [8], hip motion range [9], sitting comfort [10], don-
ning and doffing [11], osseoperception [12], and walking
ability [13, 14]. Fewer studies have reported on the safety
of osseointegrated implants in transfemoral amputees.
Two studies in amputees with screw-type implants
reported that superficial infections occurred in half of the
study population but that there was a low risk of deep
infection leading to implant removal (<3 %) [5, 15]. A
prospective multicentre study in amputees with press-fit
implants reported that there were no implant removals
secondary to infection and that the rate of superficial
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infections was lower (<30 %), when compared with ampu-
tees with screw-type implants [16].
Transfemoral amputees with a short femoral residuum
represent a challenge for rehabilitation, using not only
sockets but also osseointegrated implants. In a recent
study on prosthetic rehabilitation for amputee veterans
in the USA, the degree of amputation was significantly
associated with the prosthetic prescription, with >80 %
of the transfemoral amputees failing to receive a pros-
thesis in the first year after amputation [17]. The pros-
thetic function in such patients is severely compromised
because of limited muscle attachment and a small sur-
face area for force distribution [18]. Finding an appropri-
ate socket alignment and fit can be difficult and could
lead to a substantial proportion of patients becoming
wheelchair users [19].
The use of osseointegrated implants for transfemoral
amputees with a short residuum presents several chal-
lenges. Biomechanical studies have shown that a small
bone-implant contact area decreases the likelihood of a
structural union, thereby resulting in an increased risk of
aseptic loosening [20, 21]. Furthermore, interface load de-
pends on the degree of amputation; in those with a shorter
residuum, there is an abnormal increase in force moments
during normal gait and falling [22]. A recent comparative
study indicated that transfemoral amputees had signifi-
cantly reduced bone mineral density (BMD) at the hip and
femoral residuum, compared with the BMD in the intact
contralateral limb [23]. Such osteoporosis increases the
risks of aseptic loosening and fragility fractures of the hip.
Likewise, in older amputees with concomitant ipsilateral
hip arthritis, it has been hypothesized that the biomechan-
ical forces could aggravate arthritic symptoms [24].
Therefore, alternative implant concepts are required to
overcome these biomechanical challenges. One innovative
idea is to convert the proximal joint to weight sharing ra-
ther than weight bearing by involving it in implant fixation
by way of a joint replacement. We recently utilized this
concept by combining total knee replacement with an
osseointegrated implant in transtibial amputees who were
not eligible for standard osseointegrated implants because
of a short residuum or the presence of knee arthritis [25].
Based on that successful experience, we proposed to de-
velop this concept further and adapt it for transfemoral
amputees with a short femoral residuum.
The aim of this paper was to describe the surgical
technique and midterm results of combining a total hip
replacement (THR) with an osseointegrated implant for
prosthetic rehabilitation in transfemoral amputees.
Methods
Patients
We retrospectively reviewed the cases of three individ-
uals with transfemoral amputations who underwent an
osseointegrated implant combined with a THR at our
centre. Eligible patients included those with short trans-
femoral amputations (<10 cm) who presented with
socket-related problems and who had arthritis with or
without severe osteoporosis (Fig. 1). All patients were
treated by the investigators at the specialized ortho-
paedic osseointegration clinic. All subjects provided
written informed consent.
Surgical technique
The two-stage surgical procedure was performed with
5–8 weeks in between the procedures. An osseointe-
grated femoral prosthesis was connected to the custom-
made THR prosthesis to transfer the load directly to the
pelvis through the acetabulum. This allowed the femoral
residuum and hip joint to act as weight-sharing rather
than weight-bearing structures.
Implant design
The implant was designed and customized by the princi-
pal investigator (MAM) based on computed tomography
scans and radiographs. Each implant comprised five
components (Fig. 2). The first was a hip joint prosthesis
consisting of the acetabular cup (SUNFIT TH 69—dual
mobility acetabular cup, Novae® range, SERF, France),
which was a cementless titanium shell with an ultra-high
molecular weight polyethylene liner. The second was a
28-mm ceramic head (Biolox Forte). The third was a
Fig. 1 Radiographs of the residual bones for Case 1, 2 and 3
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modified 135° modular proximal body revision hip im-
plant made of cobalt chrome with a spongiosa coating
(Orthodynamics, Lubeck, Germany). The fourth was a
custom-made titanium stem with sharp fins placed prox-
imally and interspersed with plasma spray. This stem
allowed connection of the proximal body to the final
component that was a standard, highly polished, dual-
cone adaptor coated with niobium oxide.
Surgery stage I
The procedure was performed under a spinal anaesthetic,
and 2 g of cephazolin antibiotic was administered intra-
venously prophylactically. The hip was exposed using the
direct anterior approach [26]. An anterior capsulotomy
was performed followed by dislocation of the hip joint to
preserve the femoral head. Neck osteotomy was per-
formed using a reciprocating saw, and the femoral head/
neck was used as a structural autograft, adding length to
the femoral residuum distally. The acetabulum was pre-
pared by sequential reaming up to bleeding cancellous
bone, which was followed by press-fit implantation of an
appropriately sized acetabular shell. The sciatic nerve was
identified, and any associated neuroma was excised.
Subsequently, the femoral canal was prepared by gen-
tle broaching. The proximal body revision stem was then
press-fitted in an antegrade fashion. The modular stem
was passed through the excised femoral head to add
length to the residual femur. The modular stem was
then mechanically connected to the proximal body in a
distal position via an opening in the distal femur, and a
trial femoral head prosthesis was inserted. The hip joint
was subsequently reduced and taken through a range of
motion to assess stability, and the positions were con-
firmed using an image intensifier (Fig. 3). This was
followed by implantation of the definitive femoral head
implant. The soft tissue was refashioned followed by
reorganization of the muscles around the proximal
femur that were attached to the femoral head autograft
using intraosseous non-absorbable fibre-wire sutures.
The femoral construct was reinforced by Dall-Miles
cable placement around the graft. The subcutaneous
tissue was reduced, closing the skin nearest the distal
end of the implant, and two drains were inserted.
Surgery stage II
A guidewire was inserted distally to identify the centre of
the implant under image intensifier guidance. A stoma
was created using a cannulated coring device passed over
the guidewire through the skin. Haemostasis was achieved
at the stoma site. A dual-cone adapter was inserted in the
distal end of the femoral component and locked in place
using a screw.
Postoperative care
Wound care involved twice-daily dressing changes using
dry ribbon gauze. Sutures were removed 18–21 days
after surgery. Once the wound had granulated, patients
were instructed to wash their stoma with soap and warm
water and pat dry [25].
Rehabilitation
The rehabilitation process commenced on the day after
surgery. The Osseointegration Group of Australia Ac-
celerated Protocol was implemented, which was devel-
oped using both the THR and osseointegration fixation
guidelines [27]. Non-weight-bearing mobilization, using
a forearm support to gradually increasing hip motion
range, and core strengthening exercises were initiated
on postoperative day 3. Following the second stage of
surgery, a progressive loading regime was commenced
as described previously [25].
Outcomes
Clinical and functional outcomes were measured at base-
line and a minimum of 1.5-year follow-up. Plain radio-
graphs were conducted at baseline, 3 months, 6 months,
12 months, and each year thereafter. At follow-up, the
Fig. 2 Representation of the shape and dimensions of the total hip
replacement and osseointegration implant for case 3
Fig. 3 Examples of intraoperative radiographs for case 3, 3A
antero-posterior view, 3B lateral view
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stoma was monitored for discharge and granulation, and
any adverse events were recorded.
Functional outcomes were assessed using the physical
and mental components of Short Form 36 (SF-36) health
survey and the Questionnaire for Transfemoral Ampu-
tees (Q-TFA) [28, 29]. Ambulation ability was assessed
at baseline and at 6 and 12 months using the standard
Timed Up and Go (TUG) test and 6-min walk test
(6MWT). The Medicare Functional Classification Level
was used to classify mobility, measured as ‘K-levels’,
which were graded from K-0 (no ambulatory ability) to
K-4 (active adult) [30].
Data analyses
The differences between follow-up and baseline values
were calculated in measurement units and as a percentage
of the baseline value. A Wilcoxon test was used to test for
statistically significant differences. A p value of <0.05 was
considered significant. Analyses were conducted using the
SPSS statistical software package (Version 22).
Results
Patient characteristics
Patient characteristics are shown in Table 1. Patients in-
cluded two females and one male, aged between 35 and
65 years. All patients had a short residuum; case 1 was
7 cm, case 2 was 9 cm, and case 3 was 3.5 cm. All cases
were diagnosed with severe osteoporosis, and cases 2
and 3 had severe hip arthritis. Two patients were
wheelchair-bound, and the other, who had a customized
socket, presented with walking difficulties even for short
distances due to a host of socket-interface problems. At
baseline, patients presented with significant flexion con-
tractures of the affected hip joint varying from 15° for
case 2, who used a socket prosthesis, to 45° for case 3.
All patients complained of phantom limb pain and sen-
sation. For all cases, stage 1 of the procedure occurred
between July 2013 and July 2014. Patient follow-up
ranged from 18 to 30 months.
Clinical outcomes
All patients had a pain-free hip and a normal hip motion
range at follow-up. The phantom limb sensation was re-
duced in all three cases. All patients showed complete
healing at the 3-month follow-up (Fig. 4). None of the
cases presented with tissue granulation. One case (case
2) had a single episode of superficial infection that was
treated successfully with a week-long course of oral anti-
biotics (cephalexin 500 mg). All implants were stable
and well-aligned (Fig. 5).
Functional outcomes
All patients demonstrated improvement at follow-up for
both the physical (score improvement range, 2–16
points) and mental (score improvement range, 2–40
points) components of the SF-36. All patients showed
improvement in the Q-TFA (score improvement range,
26–42 points), although the difference was not statisti-
cally significant (p = 0.11). All cases had improved mo-
bility. On functional testing, they could cover >200 m in
the 6MWT and performed TUG in <15 s (Table 2).
Discussion
We reported the feasibility of the first three attempts to
combine an osseointegrated femoral implant with THR
for prosthetic attachment in transfemoral amputees with
a short residuum and concomitant osteoporosis.
We are not aware of any alternative techniques for re-
habilitation for this group of patients. In these patients,
the prosthetic function is usually poor because of re-
duced muscular control, improper alignment of sockets
resulting from the small surface area, and compounded
socket-skin interface problems [3, 18]. Consequently, the
majority of these patients are confined to a wheelchair
because of significantly disabling socket-interface prob-
lems when using a standard prosthesis. As is the case for
transtibial amputees, a more proximal amputation is not
an alternative option because hindquarter amputation
would have a substantially negative effect on patient mo-
bility and quality of life [18].
Existing reports suggest the efficacy of osseointegrated
implants for transfemoral amputees [14, 25, 31]. However,
the patient group described here was not considered can-
didates for osseointegrated implants because observational
data have indicated that the length of the residuum has a
significant influence on the outcome; short residuums
were associated with a high risk of failure [32]. The pres-
ence of osteoporosis is also a contraindication, and data
Table 1 Patient baseline characteristics, amputation information, and rehabilitation timeline
Case Demographics Amputation Rehabilitation timeline
Sex Age
(years)
Height
(m)
Mass
(kg)
BMI Cause Years since
amputation
Length (cm) of residuum Days between
S1 and S2
Months S1 and
follow-up(% SND)
1 F 46 1.55 47 20 Trauma 12 7.1 18 – 30
2 M 65 1.75 86 28 Tumour 19 8.7 17 58 25
3 F 35 1.45 75 36 Trauma 1 3.5 7 35 18
BMI body mass index, m metres, kg kilograms, SND sound limb
Khemka et al. Journal of Orthopaedic Surgery and Research  (2016) 11:13 Page 4 of 7
on the use of standard techniques in these patients are
lacking.
This novel concept of combining joint replacement
with osseointegrated implants was based on involving
the proximal joint in implant fixation to provide the ne-
cessary surface area for bone-implant contact and subse-
quent osseointegration. Such an approach allows direct
transmission of weight across the joint to the proximal
bone, as we demonstrated recently in transtibial ampu-
tees [25]. Therefore, this technique not only overcomes
the biomechanical challenges in these patients but also
restores proximal joint motion in those with arthritis. In
the present study, all three cases demonstrated signifi-
cantly improved functional outcome and mobility. More-
over, the two patients who were confined to a wheelchair
before the surgery regained the ability to walk.
To warrant ongoing study of this technique, the clin-
ical benefits observed must outweigh the potential
harms. The concept of a bone-anchored metal implant,
which may protrude through the skin, raises serious
concerns about the risk of ascending infection and its re-
lated local and systemic implications, more so than that
associated with joint replacement. Therefore, careful
soft-tissue management techniques and initial press-fit
implantation of the osseointegrated implant are essential
to provide a substantial seal to prevent the ascent of in-
fection. Additionally, in our experience, when compared
to the short tibial residuum, THR with osseointegration
in the short proximal femur presents further surgical
challenges related to a higher soft-tissue volume, lack of
muscle mass, and low BMD. Therefore, there might be
an increased potential for deep infection and subsequent
joint infection in this procedure, which remains our
foremost concern.
There were no serious adverse events in the present
study, although there was one case of superficial infection
that was treated using antibiotics. We have recently com-
pleted a multicentre study of 86 patients with transfemoral
amputations who received osseointegrated implants [16].
A minimum 2-year follow-up revealed that 24 patients
experienced a superficial infection that did not require
surgery, whereas 5 patients had a deep infection that re-
quired soft-tissue debridement. A recent 5-year prospect-
ive study (n = 39) reported a <2 % incidence of deep
infection leading to implant removal [15], whereas another
study (n = 51) showed a 50 % cumulative incidence of
superficial infections at a 24-month follow-up [5]. How-
ever, surgical closing techniques have been developed by
us to minimize the risk of deep implant-related infection.
The present study has limitations such as its small sam-
ple size and short follow-up duration. However, we have
developed a database for comprehensive data collection to
Fig. 4 Stoma for case 3
Fig. 5 Radiographs at follow-up for case 1, 2 and 3
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enable an assessment of procedural risks and benefits and
to identify potential predictors of treatment failure. We
envisage that these data might facilitate prospective stud-
ies to establish further evidence-based treatment proto-
cols. Longitudinal studies involving a larger cohort over
an extended follow-up period are needed to evaluate the
long-term outcomes of this novel technique.
Conclusions
This proof-of-concept study demonstrated the feasibility
of this novel surgical technique as a potential manage-
ment option for transfemoral amputees with a short
residuum and osteoporosis, who are unable to tolerate a
conventional socket prosthesis or a standard osseointe-
grated implant. It also provides preliminary evidence
concerning the safety and functional benefits of the pro-
cedure, but larger prospective studies are essential to es-
tablish the safety and effectiveness of the technique.
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